Love the news, hate the timeline.
• The duration of paxalisib’s enrollment period in GBM AGILE is expected to total
approximately 30 – 36 months, plus follow-up, but will depend on emerging study
data, recruitment rates, and other variables
- Forums
- ASX - By Stock
- Ann: Kazia executes GBM Agile study agreement
Love the news, hate the timeline.• The duration of paxalisib’s...
-
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)